Aortic Stenosis Associated Left Ventricular Remodeling - An Investigation of Genetic and Gender Specific Differences in 170 Patients Undergoing Aortic Valve Replacement Surgery - Trial NCT05696145
Access comprehensive clinical trial information for NCT05696145 through Pure Global AI's free database. This phase not specified trial is sponsored by Lisa Gundestrup and is currently Not yet recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 170 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Lisa Gundestrup
Odense University Hospital
Timeline & Enrollment
N/A
Mar 01, 2023
Jan 31, 2025
Primary Outcome
Genetic polymorphisms betweem low flow low gradient and high flow high gradient aortic stenosis patients
Summary
The goal of this study is to investigate the genetic and gender specific differences, in
 patients with low flow low gradient aortic stenosis and high flow high gradient aortic
 stenosis. Patients referred for surgical aorticvalve replacement will be offered to
 participarte in the study.
 
 The main questions the study aims to answer are:
 
 1. Low-gradient aortic stenosis is associated with differences in valvular concentration of
 the genes that code for mast-cell chymase, Angiotensin-II, ACE, ACE2 and Angiotensin
 receptor 1 and 2.
 
 2. Low-gradient aortic stenosis is associated with differences in the genetic code of
 renin-angiotensin-aldosterone system.
 
 3. Gender differences in LV remodelling associates with different levels of sexual
 hormones.
 
 Patients participating in the study will be asked to undergo:
 
 - Cardiac ultrasound, MR- and CT-scan prior to surgery
 
 - Blooddraw prior to surgery.
 
 - Heartmuscle biopsy during surgery
 
 - Cardiac MR-scan 1 year after surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05696145
Non-Device Trial

